Literature DB >> 10092824

Endotoxin fails to induce IFN-gamma in endotoxin-tolerant mice: deficiencies in both IL-12 heterodimer production and IL-12 responsiveness.

H H Balkhy1, F P Heinzel.   

Abstract

Mice exposed to sublethal endotoxemia develop short-term endotoxin tolerance, a state characterized by decreased monokine production and enhanced protection against endotoxic lethality. We confirmed that TNF-alpha production is markedly impaired in endotoxin-tolerant mice and additionally found 2- to 6-fold decreases in serum IFN-gamma in these animals following endotoxin challenge. The IFN-gamma deficiency of endotoxin tolerance correlated with 8-fold decreases in the bioactive p40/p35 heterodimeric form of IL-12. In contrast, total circulating IL-12 p40 was reduced by only 30-50%. Endotoxin-tolerant mice were less responsive to IL-12 than control mice, as evidenced by 3-fold lower levels of IFN-gamma inducible in vivo when rIL-12 was administered at the time of endotoxin challenge. Similarly, spleen cell cultures of endotoxin-tolerant mice produced 3-fold less IFN-gamma in the presence of optimal concentrations of both IL-12 and IL-18. Finally, levels of IL-12R beta 2 subunit mRNA and the percent composition of NK lymphocytes in the spleen were both decreased in endotoxin-tolerant mice relative to controls. We conclude that endotoxin-tolerant mice are profoundly impaired in their ability to produce IFN-gamma in response to endotoxin and that this is associated with acquired defects in both the production of circulating IL-12 heterodimer response and the response to IL-12 by NK cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092824

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  IL-12 suppression, enhanced endocytosis and up-regulation of MHC-II and CD80 in dendritic cells during experimental endotoxin tolerance.

Authors:  Jing Zhang; Jie-ming Qu; Li-xian He
Journal:  Acta Pharmacol Sin       Date:  2009-04-06       Impact factor: 6.150

2.  The synthetic triterpenoid, CDDO-Me, modulates the proinflammatory response to in vivo lipopolysaccharide challenge.

Authors:  Jeffery J Auletta; Jennifer L Alabran; Byung-Gyu Kim; Colin J Meyer; John J Letterio
Journal:  J Interferon Cytokine Res       Date:  2010-07       Impact factor: 2.607

3.  Deficiency of the macrophage migration inhibitory factor gene has no significant effect on endotoxaemia.

Authors:  N Honma; H Koseki; T Akasaka; T Nakayama; M Taniguchi; I Serizawa; H Akahori; M Osawa; T Mikayama
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

4.  When host defense goes awry: Modeling sepsis-induced immunosuppression.

Authors:  Scott B Hu; Alexander Zider; Jane C Deng
Journal:  Drug Discov Today Dis Models       Date:  2012

5.  A single oral dose of thalidomide enhances the capacity of lymphocytes to secrete gamma interferon in healthy humans.

Authors:  A Verbon; N P Juffermans; P Speelman; S J van Deventer; I J ten Berge; H J Guchelaar; T van der Poll
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

Review 6.  MicroRNA in TLR signaling and endotoxin tolerance.

Authors:  Md A Nahid; Minoru Satoh; Edward Kl Chan
Journal:  Cell Mol Immunol       Date:  2011-08-08       Impact factor: 11.530

7.  Cellular mechanisms that cause suppressed gamma interferon secretion in endotoxin-tolerant mice.

Authors:  T K Varma; T E Toliver-Kinsky; C Y Lin; A P Koutrouvelis; J E Nichols; E R Sherwood
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

8.  Regulation of matrix metalloproteinases and their inhibitor genes in lipopolysaccharide-induced endotoxemia in mice.

Authors:  A Pagenstecher; A K Stalder; C L Kincaid; B Volk; I L Campbell
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

9.  Modulation of T-cell costimulation as immunotherapy or immunochemotherapy in experimental visceral leishmaniasis.

Authors:  Henry W Murray; Cristina M Lu; Elaine B Brooks; Richard E Fichtl; Jennifer L DeVecchio; Frederick P Heinzel
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

10.  Immunoenhancement combined with amphotericin B as treatment for experimental visceral leishmaniasis.

Authors:  Henry W Murray; Elaine B Brooks; Jennifer L DeVecchio; Frederick P Heinzel
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.